Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Putman

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Rheumatology (Oxford, England)|April 19, 2022
Challenging wisely: how to move beyond '1 mg/kg then taper'Shannon Tai, Natalie Anumolu, Michael Putman
Rheumatology (Oxford, England)|September 4, 2023
Advocating for better trials in rheumatologySharanya Kaushik, Mats Junek, Michael Putman
The Lancet. Rheumatology|January 22, 2024
Unintentional unblinding in rheumatic disease trialsCody Bruggemeyer, Desh Nepal, Michael Putman
Rheumatology (Oxford, England)|July 8, 2023
Twenty-five years of novel drug approvals in rheumatologyKathryn Henry, Natalie Anumolu, Michael Putman
Journal of Immunological Methods|July 9, 2005
Simplified method to automatically count bacterial colony forming unitMichael Putman, Robert Burton, Moon H Nahm
Rheumatology (Oxford, England)|May 13, 2022
There is no diagnosis of exclusion in rheumatologyMichael Putman, Jayshil J Patel, Anisha Dua
Current Opinion in Rheumatology|July 18, 2020
Tracking clinical resources for coronavirus disease 2019Garret Duron, Lauren Gelman, Anisha Dua, et al.
The Lancet. Rheumatology|January 22, 2024
Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: a retrospective cohort studyShikha Singla, Michael Putman, Jean Liew, et al.
The Lancet. Rheumatology|January 22, 2024
Differentiating biologics to prevent psoriatic arthritis in patients with psoriasis - Authors' replyShikha Singla, Michael Putman, Jean Liew, et al.
Clinical Rheumatology|March 20, 2026
Increased apathy level in systemic lupus erythematosusNatalie M Anumolu, Michael Putman, David J Gazeley
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Rheumatology (Oxford, England)|April 19, 2022
Challenging wisely: how to move beyond '1 mg/kg then taper'Shannon Tai, Natalie Anumolu, Michael Putman
Rheumatology (Oxford, England)|September 4, 2023
Advocating for better trials in rheumatologySharanya Kaushik, Mats Junek, Michael Putman
The Lancet. Rheumatology|January 22, 2024
Unintentional unblinding in rheumatic disease trialsCody Bruggemeyer, Desh Nepal, Michael Putman
Rheumatology (Oxford, England)|July 8, 2023
Twenty-five years of novel drug approvals in rheumatologyKathryn Henry, Natalie Anumolu, Michael Putman
Journal of Immunological Methods|July 9, 2005
Simplified method to automatically count bacterial colony forming unitMichael Putman, Robert Burton, Moon H Nahm
Rheumatology (Oxford, England)|May 13, 2022
There is no diagnosis of exclusion in rheumatologyMichael Putman, Jayshil J Patel, Anisha Dua
Current Opinion in Rheumatology|July 18, 2020
Tracking clinical resources for coronavirus disease 2019Garret Duron, Lauren Gelman, Anisha Dua, et al.
The Lancet. Rheumatology|January 22, 2024
Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: a retrospective cohort studyShikha Singla, Michael Putman, Jean Liew, et al.
The Lancet. Rheumatology|January 22, 2024
Differentiating biologics to prevent psoriatic arthritis in patients with psoriasis - Authors' replyShikha Singla, Michael Putman, Jean Liew, et al.
Clinical Rheumatology|March 20, 2026
Increased apathy level in systemic lupus erythematosusNatalie M Anumolu, Michael Putman, David J Gazeley
Pageof 6